Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
XELA
|
Srinivasan Murali
President, Americas and APAC |
BUY
Exercise of conversion of derivative security
|
Direct | 26,667 Added 17.51% |
-
|
Mar 03
2022 |
XELA
|
Shrikant Sortur
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 10,170 Reduced 9.59% |
$8,034
$0.79 p/Share
|
Mar 03
2022 |
XELA
|
Shrikant Sortur
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 30,000 Added 22.05% |
-
|
Mar 03
2022 |
XELA
|
Suresh Yannamani
President |
BUY
Exercise of conversion of derivative security
|
Direct | 25,000 Added 11.33% |
-
|
Mar 03
2022 |
PDCE
|
Lance Lauck
EVP, Corp. Dev. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct | 14,221 Reduced 6.73% |
$950,674
$66.85 p/Share
|
Mar 03
2022 |
PDCE
|
Lance Lauck
EVP, Corp. Dev. & Strategy |
BUY
Exercise of conversion of derivative security
|
Direct | 20,192 Added 8.72% |
$875,929
$43.38 p/Share
|
Mar 03
2022 |
PDCE
|
Lance Lauck
EVP, Corp. Dev. & Strategy |
SELL
Open market or private sale
|
Direct | 4,523 Reduced 2.3% |
$305,031
$67.44 p/Share
|
Mar 03
2022 |
PBBK
|
Larry Witt
Chief Info. & Oper. Officer |
BUY
Small Acquisition
|
Indirect | 14 Added 5.6% |
$195
$13.9 p/Share
|
Mar 03
2022 |
HMHC
|
Michael Dolan
SVP, Controller |
BUY
Exercise of conversion of derivative security
|
Direct | 9,615 Added 24.74% |
-
|
Mar 03
2022 |
ANAT
|
Frances A Moody Dahlberg
Director |
SELL
Open market or private sale
|
Indirect | 23,974 Reduced 61.4% |
$4,532,045
$189.04 p/Share
|
Mar 03
2022 |
ANAT
|
Russell S. Moody |
SELL
Open market or private sale
|
Indirect | 2,869 Reduced 7.35% |
$542,930
$189.24 p/Share
|
Mar 03
2022 |
CPLG
|
B Anthony Isaac
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 21,769 Reduced 100.0% |
$348,086
$15.99 p/Share
|
Mar 03
2022 |
CPLG
|
David Loeb
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 29,419 Reduced 100.0% |
$470,410
$15.99 p/Share
|
Mar 03
2022 |
CPLG
|
Howard Steven Garfield
SVP, CAO & Treasurer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 134,631 Reduced 100.0% |
$2,152,750
$15.99 p/Share
|
Mar 03
2022 |
CPLG
|
Glenn Alba
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 25,688 Reduced 100.0% |
$410,751
$15.99 p/Share
|
Mar 03
2022 |
CPLG
|
Alice E Gould
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 20,354 Reduced 100.0% |
$325,460
$15.99 p/Share
|
Mar 03
2022 |
CPLG
|
Mitesh B. Shah
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 4,989 Reduced 100.0% |
$79,774
$15.99 p/Share
|
Mar 03
2022 |
CPLG
|
Mark M. Chloupek
Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 474,421 Reduced 100.0% |
$7,585,992
$15.99 p/Share
|
Mar 03
2022 |
CPLG
|
Blackstone Real Estate Associates V L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 17,586,538 Reduced 100.0% |
$281,208,739
$15.99 p/Share
|
Mar 03
2022 |
CPLG
|
Daniel E Swanstrom Ii
EVP and CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 384,224 Reduced 100.0% |
$6,143,742
$15.99 p/Share
|
Mar 03
2022 |
CPLG
|
Bre/Lqjv Nq L.L.C.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 17,586,538 Reduced 100.0% |
$281,208,739
$15.99 p/Share
|
Mar 03
2022 |
CPLG
|
Alan J Bowers
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 26,577 Reduced 100.0% |
$424,966
$15.99 p/Share
|
Mar 03
2022 |
CPLG
|
James R Abrahamson
Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 27,421 Reduced 100.0% |
$438,462
$15.99 p/Share
|
Mar 03
2022 |
CPLG
|
James R Abrahamson
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 4,158 Reduced 100.0% |
$66,486
$15.99 p/Share
|
Mar 03
2022 |
CPLG
|
Keith A. Cline
President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,480,676 Reduced 100.0% |
$23,676,009
$15.99 p/Share
|
Mar 03
2022 |
CPLG
|
Jean Birch
Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 16,750 Reduced 100.0% |
$267,832
$15.99 p/Share
|
Mar 03
2022 |
CPLG
|
Jean Birch
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 3,604 Reduced 100.0% |
$57,628
$15.99 p/Share
|
Mar 03
2022 |
ISBC
|
P. Sean Burke
EVP and CFO |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 37.2% |
$1,622,000
$16.22 p/Share
|
Mar 03
2022 |
ISBC
|
P. Sean Burke
EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 100,000 Added 27.11% |
$1,254,000
$12.54 p/Share
|
Mar 03
2022 |
MSP
|
John Abbot
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 100.0% |
$94,680
$23.67 p/Share
|
Mar 03
2022 |
MSP
|
John Abbot
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 4,000 Added 50.0% |
$51,200
$12.8 p/Share
|
Mar 03
2022 |
FOMC
|
Charles Attila Szoradi
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 4,401 Reduced 0.01% |
-
|
Mar 03
2022 |
STRR
|
Jeffrey E. Eberwein
Executive Chairman |
SELL
Open market or private sale
|
Direct | 206 Reduced 0.02% |
$2,161
$10.49 p/Share
|
Mar 03
2022 |
GPFT
|
Daniel J. Yourist
COO |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 0.08% |
$3,000
$0.03 p/Share
|
Mar 03
2022 |
MODD
|
William J Febbo
Director |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 21.48% |
$80,400
$4.02 p/Share
|
Mar 03
2022 |
FLUX
|
John A Cosentino Jr |
BUY
Grant, award, or other acquisition
|
Direct | 4,578 Added 6.37% |
-
|
Mar 03
2022 |
NMTR
|
Mark A Sirgo
Director |
BUY
Open market or private purchase
|
Direct | 86,449 Added 6.33% |
$50,140
$0.58 p/Share
|
Mar 03
2022 |
TURN
|
Daniel B Wolfe
President |
BUY
Open market or private purchase
|
Direct | 2,500 Added 1.34% |
$17,225
$6.89 p/Share
|
Mar 03
2022 |
EOSE
|
Daniel Shribman |
BUY
Open market or private purchase
|
Direct | 10,000 Added 0.98% |
$36,200
$3.62 p/Share
|
Mar 03
2022 |
EOSE
|
Marian Walters
Director |
BUY
Open market or private purchase
|
Indirect | 5,000 Added 50.0% |
$17,800
$3.56 p/Share
|
Mar 03
2022 |
EOSE
|
Audrey Ann Zibelman
Director |
BUY
Open market or private purchase
|
Direct | 50 Added 0.94% |
$185
$3.69 p/Share
|
Mar 03
2022 |
EOSE
|
Claude Demby
Director |
BUY
Open market or private purchase
|
Direct | 13,200 Added 50.0% |
$50,028
$3.79 p/Share
|
Mar 03
2022 |
CXDO
|
Steven G Mihaylo |
BUY
Open market or private purchase
|
Direct | 3,000 Added 0.03% |
$12,780
$4.26 p/Share
|
Mar 03
2022 |
FTK
|
Nicholas J. Bigney
SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 8,445 Reduced 3.45% |
$11,907
$1.41 p/Share
|
Mar 03
2022 |
FTK
|
Ryan Gillis Ezell
CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 10,134 Reduced 2.82% |
$14,289
$1.41 p/Share
|
Mar 03
2022 |
FTK
|
James A Silas
SVP Research and Innovation |
SELL
Payment of exercise price or tax liability
|
Direct | 9,627 Reduced 2.59% |
$13,574
$1.41 p/Share
|
Mar 03
2022 |
DRTT
|
Steven Parry
Director |
BUY
Grant, award, or other acquisition
|
Direct | 10,000 Added 14.86% |
$17,100
$1.71 p/Share
|
Mar 03
2022 |
AUGG
|
Augusta Investments Inc. |
BUY
Open market or private purchase
|
Direct | 16,800 Added 0.08% |
$14,448
$0.86 p/Share
|
Mar 03
2022 |
CSBB
|
Julian L Coblentz |
BUY
Open market or private purchase
|
Indirect | 400 Added 6.45% |
$15,600
$39.0 p/Share
|
Mar 03
2022 |
NPCE
|
Martha Morrell
CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 46,760 Added 45.25% |
-
|
Mar 03
2022 |